Estrine 140 Capsule contains Estramustine 140mg, a specialized oncology therapy medicine widely used in the management of prostate cancer. It combines cytostatic and estrogenic properties to slow the progression of cancer cells while supporting palliative treatment.
This 140mg dosage is commonly prescribed for patients requiring oral anticancer therapy, offering effective disease management with convenient administration. It is used in hospital oncology wards, outpatient cancer clinics, and specialty treatment centers.
For distributors and hospital suppliers, Estrine 140 Capsule is a high-demand oncology product, regularly prescribed in prostate cancer treatment regimens. Its targeted efficacy ensures consistent prescription, repeated orders, and strong institutional demand.
Adding Estrine 140 Capsule to your portfolio strengthens your oncology and cancer-care segment, creating opportunities in hospital supply, pharmacy distribution, institutional tenders, export markets, and third-party manufacturing. Its clinical significance and strong prescription base make it a valuable product for pharmaceutical distributors.